Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.
Journal Information
Full Title: Respir Med
Abbreviation: Respir Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of competing interest Stina Selberg declarations of interest: none. Johanna Karlsson Sundbaum declarations of interest: none. Jon R. Konradsen declarations of interest: none. Helena Backman has received personal fees for scientific presentations from AstraZeneca, Boehringer Ingelheim, and Glaxo Smith Kline, outside the submitted work. Linnea Hedman declarations of interest: none. Anne Lindberg reports personal fees from Boehringer Ingelheim, GlaxoKlineSmith, AztraZeneca and Novartis outside the submitted work. Caroline Stridsman has served in an advisory board and/or participated in education arranged by AstraZeneca, Boehringer Ingelheim, and Novartis."
"Funding This work was supported by the 10.13039/501100003793Swedish Heart-Lung Foundation under Grant 20200308, the 10.13039/501100010234Asthma and Allergy Association, Region Norrbotten and the Swedish Respiratory Society."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025